 |
市场调查报告书
商品编码
1658133
特殊非专利市场规模、份额和成长分析（按类型、应用、分销管道和地区）- 产业预测 2025-2032Specialty Generics Market Size, Share, and Growth Analysis, By Type (Injectables, Oral Drugs), By Application (Oncology, Inflammatory Conditions), By Distribution Channel, By Region - Industry Forecast 2025-2032 |
||||||
预计特种非专利市场规模将在 2023 年达到 824 亿美元，并从 2024 年的 905.6 亿美元增长到 2032 年的 1927.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.9%。
全球特种非专利市场专注于针对特定疾病的独特的、专利到期药物，由于对品牌药物的平价替代品的需求不断增加、专利到期和控制医疗成本的努力，该市场正在经历显着增长。儘管面临配方复杂、治疗领域多样和监管障碍等挑战，但该市场仍因能够提供具有成本效益的治疗方法而提供了机会。製药公司优先考虑市场开发、生产和合规，同时也建立策略联盟和收购以加强其市场地位。医疗政策变化、定价压力和药物传输技术进步将进一步影响市场的发展，最终影响创新和可及治疗方法的可用性。
目录
介绍
- 调查目的
- 研究范围
- 定义
调查方法
- 资讯采购
- 次要和主要资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分机会分析
市场动态及展望
- 市场概况
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特的分析
主要市场考察
- 关键成功因素
- 竞争程度
- 主要投资机会
- 市场生态系统
- 市场吸引力指数（2024 年）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
- 监管分析
特殊非专利市场规模（按类型和复合年增长率） (2025-2032)
- 市场概况
- 注射
- 口服药物
特殊非专利市场规模（按应用划分）及复合年增长率（2025-2032）
- 市场概况
- 肿瘤学
- 发炎性疾病
- C型肝炎
- 多发性硬化症
- 其他用途
特殊非专利市场规模（按分销管道和复合年增长率） (2025-2032)
- 市场概况
- 专业药房
- 零售药局
- 医院药房
- 其他分销管道
特殊非专利市场规模（按地区划分）及复合年增长率（2025-2032）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲国家
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前 5 家公司对比
- 主要企业市场定位（2024年）
- 主要市场参与者所采用的策略
- 近期市场趋势
- 公司市场占有率分析（2024 年）
- 主要企业简介
- 公司详细信息
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）
主要企业简介
- Teva Pharmaceuticals（Israel）
- Sandoz（Switzerland）
- Sun Pharma（India）
- Viatris（United States）
- Biocon（India）
- Aurobindo Pharma（India）
- Fresenius Kabi（Germany）
- Cipla（India）
- Dr. Reddy's Laboratories（India）
- Aspen（South Africa）
- Lupin（India）
- Mallinckrodt（Ireland）
- Zydus（India）
- KRKA（Slovenia）
- Glenmark（India）
- Stada（Germany）
- Amneal（United States）
- Towa（Japan）
- Sawai（Japan）
- Hikma（Jordan）
结论和建议
Specialty Generics Market size was valued at USD 82.4 billion in 2023 and is poised to grow from USD 90.56 billion in 2024 to USD 192.71 billion by 2032, growing at a CAGR of 9.9% during the forecast period (2025-2032).
The global specialty generics market, which focuses on unique off-patent medications for specific conditions, is experiencing significant growth driven by the increasing demand for affordable alternatives to brand-name drugs, the expiration of patents, and efforts to control healthcare costs. This market presents opportunities through its ability to provide cost-effective treatments, although it faces challenges such as complex formulations, a variety of therapeutic areas, and regulatory barriers. Pharmaceutical companies are prioritizing development, production, and compliance while engaging in strategic partnerships and acquisitions to enhance their market positions. The market's evolution is further shaped by changing healthcare policies, pricing pressures, and advancements in drug delivery technologies, ultimately influencing the availability of innovative and accessible therapies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Specialty Generics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Specialty Generics Market Segments Analysis
Global Specialty Generics Market is segmented by Type, Application, Distribution Channel and region. Based on Type, the market is segmented into Injectables and Oral Drugs. Based on Application, the market is segmented into Oncology, Inflammatory Conditions, Hepatitis C, Multiple Sclerosis and Other Applications. Based on Distribution Channel, the market is segmented into Specialty Pharmacy, Retail Pharmacy, Hospital Pharmacy and Other Distribution Channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Specialty Generics Market
The specialty generics market is primarily driven by the increasing demand for cost-effective alternatives to brand-name specialty medications. These generics offer a more affordable solution for patients and healthcare providers, particularly in light of rising healthcare expenses. As more individuals seek budget-friendly treatment options for complex and chronic conditions, the appeal of specialty generics continues to grow. This demand underscores the importance of providing accessible medication solutions, thereby fueling the expansion of the specialty generics market as it aligns with the overall goal of making healthcare more affordable and manageable for a broader range of patients.
Restraints in the Specialty Generics Market
The Specialty Generics market faces significant constraints due to the intricate nature of its formulations, delivery systems, and manufacturing methods. The production and development of these medications necessitate a high level of specialized knowledge and infrastructure, which can be a barrier for many manufacturers. As a result, this complexity restricts the number of companies equipped to create specialty generics, potentially resulting in supply shortages. The challenges associated with producing these advanced medications underscore the need for substantial investment and expertise, ultimately limiting the overall availability and accessibility of specialty generics in the market.
Market Trends of the Specialty Generics Market
The Specialty Generics market is experiencing a robust trend towards complex generics, driven by an increasing demand for advanced medications that offer significant therapeutic benefits at reduced costs. These generics, characterized by their intricate formulations and sophisticated delivery systems, are gaining traction due to their ability to effectively address conditions like cancer, central nervous system disorders, and autoimmune diseases. As healthcare providers and patients seek more tailored treatment options, the need for expertise and innovation in developing products such as extended-release formulations, inhalation devices, and biosimilars is rising. This shift is fostering investment and driving growth in the specialty generics sector, promising substantial market potential.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Analysis
Global Specialty Generics Market Size by Type & CAGR (2025-2032)
- Market Overview
- Injectables
- Oral Drugs
Global Specialty Generics Market Size by Application & CAGR (2025-2032)
- Market Overview
- Oncology
- Inflammatory Conditions
- Hepatitis C
- Multiple Sclerosis
- Other Applications
Global Specialty Generics Market Size by Distribution Channel & CAGR (2025-2032)
- Market Overview
- Specialty Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
- Other Distribution Channels
Global Specialty Generics Market Size & CAGR (2025-2032)
- North America (Type, Application, Distribution Channel)
- US
- Canada
- Europe (Type, Application, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Application, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Application, Distribution Channel)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Application, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Teva Pharmaceuticals (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sandoz (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viatris (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biocon (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aurobindo Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius Kabi (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dr. Reddy's Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aspen (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lupin (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mallinckrodt (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zydus (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- KRKA (Slovenia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Glenmark (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stada (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amneal (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Towa (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sawai (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hikma (Jordan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
特殊仿製药市场 - 全球产业规模、份额、趋势、机会和预测，按给药途径、按适应症、按配销通路、按地区和竞争进行细分，2020-2030 年预测
2025-2033 年按治疗领域、药物传输、配销通路和国家分類的仿製药市场报告2025-2033 年按给药途径、适应症、配销通路和地区分類的特种仿製药市场报告
生物等效性测试市场 - 2025 年至 2030 年预测学名药市场：按类型、给药途径、适应症、药物、分销分类 - 全球预测 2025-2030特种非专利市场：按类型、应用和最终用途 - 2025-2030 年全球预测
学名药市场规模、份额、成长分析、按类型、按品牌、按适应症、按给药途径、按分销管道、按地区 - 行业预测，2024-2031 年
印度的学名药市场评估:各用途，各类型，不同品牌，各给药途径，各流通管道，各地区，机会，预测(2018年度～2032年度)学名药的日本市场评估:各用途，各类型，不同品牌，各给药途径，各流通管道，各地区，机会，预测(2018年度～2032年度)学名药的美国市场的评估:各用途，各类型，不同品牌，各给药途径，各流通管道，各地区，机会，预测(2017年～2031年)